Kinfimsa Design

Class [005]
Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, sclerosis, atherosclerosis, diabetic nephropathy, stroke, heart attack, hypercholesterolemia, dyslipidemia, anemia, blood disorders, diabetes, thyroid function disease, cancer, oncological disease, leukemia, metastasis, autoimmune disease, rheumatoid arthritis, allergy, bacterial infection of skin, soft tissue, spinal cord, endocrine, respiratory, and central nervous system, viral infection of skin, soft tissue, spinal cord, endocrine, respiratory, and central nervous system, fungal infection, inflammation, namely anti-inflammatories, sepsis, spinal cord injury, pain, central nervous system diseases and neurological diseases namely spinal cord diseases and brain diseases, mood disorders, osteoporosis, Alzheimer's disease, obesity, anorexia, urinary tract infections and kidney disease, respiratory disease, gastrointestinal disease, constipation; pharmaceutical preparations for the treatment and prevention of musculoskeletal disorders, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations in the form of vaccines for human use for the prevention and treatment of infectious diseases, namely, influenza vaccines, diphtheria vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, measles vaccines, rubella vaccines, parotitis vaccines, pertussis vaccines, poliomyelitis vaccines and the above combined vaccines; pharmaceutical preparations, namely diagnostic contrast agents for ultrasound imaging, X-ray imaging, magnetic resonance imaging, optical imaging, nuclear imaging and other imaging modalities based on the difference in physicochemical properties such as electrical, thermal, acoustic and optical conductivity and transmittance.